Pulse Biosciences Investor Relations Material
Latest events
Q3 2023
Pulse Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Pulse Biosciences, Inc. (Pulse) is a novel bioelectric medicine company. The Company focuses on the development of its product candidate, the NBE chip, which provides real-time localized electrocardiogram (ECG) data in an ambulatory setting. Pulse's proprietary technology utilizes predefined algorithms to provide analysis and measurement features to improve clinical outcomes following a procedure at the point of care.
Latest articles
Webull vs Robinhood: Which Platform Suits You?
In the competitive world of online trading platforms, Webull and Robinhood have emerged as two of the top choices for investors.
24 Nov 2023
Norway's Sovereign Wealth Fund: Transforming Oil Wealth into Lasting Prosperity
But what makes Norway’s striking of oil so fundamentally different from its worse faring counterparts? The answer is in large part its Norwegian Government Pension fund, and Norges Bank Investment Management
24 Nov 2023
Danaher Business System and Acquisition History
Since the early 1990s, Danaher's management team has transformed a group of under-performing industrial manufacturing companies into a global powerhouse in life sciences and diagnostics.
22 Nov 2023
Ticker symbol
PLSE
Country
🇺🇸 United States